J&J Settles Latest Risperdal Case Before Trial

Law360, Philadelphia (January 6, 2017, 5:23 PM EST) -- Ahead of a trial that was scheduled to get underway in Philadelphia beginning on Monday, a Johnson & Johnson unit has agreed to settle a lawsuit alleging that a New York boy grew female breasts after being treated with the antipsychotic drug Risperdal.

The settlement comes as Janssen Pharmaceuticals Inc. was gearing up to face what would have been the seventh trial over breast growth allegedly linked to the powerful antipsychotic since juries began hearing cases over the drug in earnest two years ago.

“We resolved...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.